SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Dec-23 6:21 PM View: | Quince Therapeutics, Inc. (QNCX) | 14-Dec-23 | Purchase | 22,627 | $1.04 | $23,532.10 | < 1% 6.66M to 6.69M | |
14-Dec-23 6:21 PM View: | Quince Therapeutics, Inc. (QNCX) | 13-Dec-23 | Purchase | 22,627 | $1.00 | $22,627.00 | < 1% 6.64M to 6.66M | |
14-Dec-23 6:21 PM View: | Quince Therapeutics, Inc. (QNCX) | 12-Dec-23 | Private Purchase | 300 | $1.00 | $300.00 | < 1% 6.6M to 6.6M | |
14-Dec-23 6:21 PM View: | Quince Therapeutics, Inc. (QNCX) | 12-Dec-23 | Purchase | 22,327 | $1.02 | $22,773.50 | < 1% 6.6M to 6.62M | |
07-Dec-23 6:30 PM View: | Quince Therapeutics, Inc. (QNCX) | 07-Dec-23 | Purchase | 19,123 | $1.01 | $19,314.20 | < 1% 4.3M to 4.32M | |
07-Dec-23 6:30 PM View: | Quince Therapeutics, Inc. (QNCX) | 06-Dec-23 | Purchase | 19,123 | $1.02 | $19,505.50 | < 1% 4.28M to 4.3M | |
07-Dec-23 6:30 PM View: | Quince Therapeutics, Inc. (QNCX) | 05-Dec-23 | Private Purchase | 19,123 | $1.01 | $19,314.20 | < 1% 4.26M to 4.28M | |
01-Dec-23 1:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 01-Dec-23 | Purchase | 14,378 | $0.94 | $13,515.30 | < 1% 4.24M to 4.26M | |
01-Dec-23 1:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 30-Nov-23 | Purchase | 14,378 | $0.90 | $12,940.20 | < 1% 4.23M to 4.24M | |
01-Dec-23 1:38 PM View: | Quince Therapeutics, Inc. (QNCX) | 29-Nov-23 | Private Purchase | 14,378 | $0.98 | $14,090.40 | < 1% 4.22M to 4.23M | |
31-Aug-23 6:42 PM View: | Quince Therapeutics, Inc. (QNCX) | 31-Aug-23 | Purchase | 41,026 | $1.32 | $54,154.30 | < 1% 4.17M to 4.22M | |
31-Aug-23 6:42 PM View: | Quince Therapeutics, Inc. (QNCX) | 30-Aug-23 | Private Purchase | 41,026 | $1.31 | $53,744.10 | < 1% 4.13M to 4.17M | |
17-Aug-23 6:08 PM View: | Quince Therapeutics, Inc. (QNCX) | 17-Aug-23 | Purchase | 24,766 | $1.29 | $31,948.10 | < 1% 4.11M to 4.13M | |
17-Aug-23 6:08 PM View: | Quince Therapeutics, Inc. (QNCX) | 16-Aug-23 | Purchase | 117,348 | $1.29 | $151,379.00 | 3% 3.99M to 4.11M | |
17-Aug-23 6:08 PM View: | Quince Therapeutics, Inc. (QNCX) | 15-Aug-23 | Private Purchase | 107,886 | $1.32 | $142,410.00 | 3% 3.88M to 3.99M | |
23-May-22 6:18 PM View: | Applied Molecular Transport... (AMTI) | 23-May-22 | Purchase | 33,500 | $3.26 | $109,210.00 | 3% 1.04M to 1.08M | |
23-May-22 6:18 PM View: | Applied Molecular Transport... (AMTI) | 20-May-22 | Private Purchase | 33,000 | $3.08 | $101,640.00 | 3% 1.01M to 1.04M | |
23-May-22 8:09 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-May-22 | Grant | 200,002 | -- | -- | 5% 3.68M to 3.88M | |
07-Apr-21 6:47 PM View: | Applied Molecular Transport... (AMTI) | 06-Apr-21 | Private Purchase | 25,000 | $42.00 | $1,050,000.00 | 3% 986.02K to 1.01M | |
24-Mar-21 9:06 PM View: | Quince Therapeutics, Inc. (QNCX) | 24-Mar-21 | Market Purchase | 50,000 | $33.77 | $1,688,500.00 | 1% 3.63M to 3.68M | 2% |
23-Mar-21 7:13 PM View: | Quince Therapeutics, Inc. (QNCX) | 04-Mar-21 | Gift | 1,534,720 | -- | -- | 73% 2.1M to 3.63M | |
05-Mar-21 5:54 PM View: | Quince Therapeutics, Inc. (QNCX) | 04-Mar-21 | Market Purchase | 50,000 | $35.34 | $1,767,060.00 | 2% 2.05M to 2.1M | 3% |
09-Feb-21 7:50 PM View: | Lucira Health, Inc. (LHDX) | 09-Feb-21 | Conversion | 146,385 | -- | -- | 117% 125.28K to 271.67K | |
11-Jun-20 6:38 PM View: | Applied Molecular Transport... (AMTI) | 09-Jun-20 | Grant | 71,430 | $14.00 | $1,000,020.00 | 100% 0 to 71.43K | |
11-Jun-20 6:38 PM View: | Applied Molecular Transport... (AMTI) | 09-Jun-20 | Conversion | 914,589 | -- | -- | 1280% 71.43K to 986.02K | |
08-Jun-20 6:47 PM View: | Quince Therapeutics, Inc. (QNCX) | 04-Jun-20 | Market Purchase | 49,125 | $43.27 | $2,125,790.00 | 2% 2.0M to 2.05M | (32%) |
19-May-20 6:41 PM View: | Quince Therapeutics, Inc. (QNCX) | 19-May-20 | Market Purchase | 39,200 | $56.24 | $2,204,680.00 | 2% 1.96M to 2.0M | (48%) |
19-May-20 6:41 PM View: | Quince Therapeutics, Inc. (QNCX) | 15-May-20 | Market Purchase | 5,448 | $48.93 | $266,569.00 | < 1% 1.96M to 1.96M | (40%) |
10-Feb-20 6:18 PM View: | Quince Therapeutics, Inc. (QNCX) | 10-Feb-20 | Grant | 30,000 | $50.00 | $1,500,000.00 | 2% 1.93M to 1.96M | (41%) |
13-May-19 7:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 13-May-19 | Conversion | 1,623,340 | -- | -- | 100% 0 to 1.62M | |
13-May-19 7:48 PM View: | Quince Therapeutics, Inc. (QNCX) | 13-May-19 | Conversion | 301,829 | -- | -- | 19% 1.62M to 1.93M |